E. Berg

Auranofin treatment in early rheumatoid arthritis may postpone early retirement. Results from a 2-year double blind trial.

U. Brodin, E. Allander, G. Borg, 1991, The Journal of rheumatology.

Auranofin (SK&F) in early rheumatoid arthritis: results from a 24-month double-blind, placebo-controlled study. Effect on clinical and biochemical assessments.

U. Brodin, G. Borg, E. Berg, 1989, Scandinavian journal of rheumatology.

Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 year followup of a prospective double blind placebo controlled study.

U. Brodin, H. Pettersson, G. Borg, 1995, The Journal of rheumatology.

Auranofin improves outcome in early rheumatoid arthritis. Results from a 2-year, double blind placebo controlled study.

U. Brodin, H. Pettersson, E. Allander, 1988, The Journal of rheumatology.

Effects of two regimens of antibiotic prophylaxis on colonizing flora of the respiratory tract in patients with cardiovascular surgery

R. Wesselink, E. Berg, M. Tersmette, 2010, Critical Care.

Health-related quality-of-life up to one year after myocardial infarction with non-obstructive coronary arteries

K. Cederlund, S. Agewall, P. Tornvall, 2022, European Heart Journal - Quality of Care and Clinical Outcomes.